Response to Facciorusso et al

Authors :: Xiaobin Feng
Kuansheng Ma
Source :: American Journal of Gastroenterology. 110:771-773
Publication Year :: 2015
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2015.
Abstract: To the Editor: We thank you very much for your kind comments, Combination Therapy with Sorafenib and Radiofrequency Ablation for Hepatocellular Carcinoma: a Glimmer of Light after the STORM Trial? (1). We appreciate the professional and precise point of view on this study, which will undoubtedly help us improve our understanding.